相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Epigenetic drivers of tumourigenesis and cancer metastasis
Aniruddha Chatterjee et al.
SEMINARS IN CANCER BIOLOGY (2018)
Impact of 68Ga-PSMA PET on the Management of Patients with Prostate Cancer: A Systematic Review and Meta-analysis
Sangwon Han et al.
EUROPEAN UROLOGY (2018)
Does nonmetastatic castration-resistant prostate cancer still exist?
Celestia S. Higano
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Extracellular vesicles in cancer - implications for future improvements in cancer care
Rong Xu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Early stage NSCLC - challenges to implementing ctDNA-based screening and MRD detection
Christopher Abbosh et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Clinical utility of circulating non-coding RNAs - an update
Simone Anfossi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy
Jordan A. Krall et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma
Melanie Werner-Klein et al.
NATURE COMMUNICATIONS (2018)
Adjuvant denosumab in early breast cancer: Disease-free survival analysis of 3,425 postmenopausal patients in the ABCSG-18 trial.
Michael Gnant et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Adjuvant denosumab in early breast cancer: First results from the international multicenter randomized phase III placebo controlled D-CARE study.
Robert E. Coleman et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy
Luc Cabel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing Melanoma
Andrew J. Haak et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target
U. Saini et al.
ONCOGENE (2017)
Selective function-blocking monoclonal human antibody highlights the important role of membrane type-1 matrix metalloproteinase (MT1-MMP) in metastasis
Albert G. Remacle et al.
ONCOTARGET (2017)
Zebrafish xenograft models of cancer and metastasis for drug discovery
Hannah K. Brown et al.
EXPERT OPINION ON DRUG DISCOVERY (2017)
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh et al.
NATURE (2017)
Radiotherapy and immunotherapy: a beneficial liaison?
Ralph R. Weichselbaum et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Dual-activity PI3K-BRD4 inhibitor for the orthogonal inhibition of MYC to block tumor growth and metastasis
Forest H. Andrews et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer
Jing Zhang et al.
RADIATION ONCOLOGY (2017)
A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action
Elena Campaner et al.
NATURE COMMUNICATIONS (2017)
Metas-Chip precisely identifies presence of micrometastasis in live biopsy samples by label free approach
Mohammad Saeid Nikshoar et al.
NATURE COMMUNICATIONS (2017)
Mutational profiles of breast cancer metastases from a rapid autopsy series reveal multiple evolutionary trajectories
Bracha Erlanger Avigdor et al.
JCI INSIGHT (2017)
Underlying Mechanisms for Distant Metastasis - Molecular Biology
Eva Pachmayr et al.
VISCERAL MEDICINE (2017)
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
Sidharth V. Puram et al.
CELL (2017)
Whole-Body MRI: Current Applications in Oncology
Mario Morone et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2017)
Preclinical mouse solid tumour models: status quo, challenges and perspectives
Nicolas Gengenbacher et al.
NATURE REVIEWS CANCER (2017)
High-Contrast Fluorescence Detection of Metastatic Breast Cancer Including Bone and Liver Micrometastases via Size-Controlled pH-Activatable Water-Soluble Probes
Hu Xiong et al.
ADVANCED MATERIALS (2017)
Circulating tumor cells and CDX models as a tool for preclinical drug development
Alice Lallo et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2017)
The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome
Deborah R. Caswell et al.
BMC MEDICINE (2017)
Pre-metastatic niches: organ-specific homes for metastases
Hector Peinado et al.
NATURE REVIEWS CANCER (2017)
Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis
Ting Kang et al.
ACS NANO (2017)
Tumor cell intravasation
Serena P. H. Chiang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2016)
Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies
M. F. Sanmamed et al.
ANNALS OF ONCOLOGY (2016)
Therapeutic inhibition of breast cancer bone metastasis progression and lung colonization: breaking the vicious cycle by targeting α5β1 integrin
Hongren Yao et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Factors influencing recurrence following initial hepatectomy for colorectal liver metastases
J. Hallet et al.
BRITISH JOURNAL OF SURGERY (2016)
Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma
Massimiliano Cadamuro et al.
CANCER RESEARCH (2016)
Blood Worth Bottling: Circulating Tumor DNA as a Cancer Biomarker
Elizabeth L. Christie et al.
CANCER RESEARCH (2016)
Impact of Blood-Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases
Matthias Osswald et al.
CLINICAL CANCER RESEARCH (2016)
Disseminated tumor cells and dormancy in prostate cancer metastasis
Emma E. van der Toom et al.
CURRENT OPINION IN BIOTECHNOLOGY (2016)
Repositioning of drugs for intervention in tumor progression and metastasis: Old drugs for new targets
Giridhar Mudduluru et al.
DRUG RESISTANCE UPDATES (2016)
Gaining ground on a cure through synergy: combining checkpoint inhibitors with cancer vaccines
T. J. Vreeland et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2016)
Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial
Mustafa Khasraw et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Anti-stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma
Elisabete F. Carapuca et al.
JOURNAL OF PATHOLOGY (2016)
Strength of Validation for Surrogate End Points Used in the US Food and Drug Administration's Approval of Oncology Drugs
Chul Kim et al.
MAYO CLINIC PROCEEDINGS (2016)
Inhibition of Breast Cancer Metastasis by Presurgical Treatment with an Oral Matrix Metalloproteinase Inhibitor: A Preclinical Proof-of-Principle Study
Arthur Winer et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Early dissemination seeds metastasis in breast cancer
Hedayatollah Hosseini et al.
NATURE (2016)
Mechanism of early dissemination and metastasis in Her2+ mammary cancer
Kathryn L. Harper et al.
NATURE (2016)
Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis
Sebastian R. Nielsen et al.
NATURE CELL BIOLOGY (2016)
Therapeutic targeting of tetraspanin8 in epithelial ovarian cancer invasion and metastasis
C. S. Park et al.
ONCOGENE (2016)
Lymph Node Micrometastases and In-Transit Metastases from Melanoma: In Vivo Detection with Multispectral Optoacoustic Imaging in a Mouse Model
Volker Neuschmelting et al.
RADIOLOGY (2016)
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
Catherine Alix-Panabieres et al.
CANCER DISCOVERY (2016)
A cross-sectional study comparing a blood test for methylated BCAT1 and IKZF1 tumor-derived DNA with CEA for detection of recurrent colorectal cancer
Graeme P. Young et al.
CANCER MEDICINE (2016)
Early drug development: assessment of proarrhythmic risk and cardiovascular safety: The age of repolarization cardiac toxicity
Robert M. Lester et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2016)
AECHL-1 targets breast cancer progression via inhibition of metastasis, prevention of EMT and suppression of Cancer Stem Cell characteristics
Aparajita Dasgupta et al.
SCIENTIFIC REPORTS (2016)
Radiotherapy: Changing the Game in Immunotherapy
Sandra Demaria et al.
TRENDS IN CANCER (2016)
Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation
Lori E. Lowes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
The challenge of targeting metastasis
Isaiah J. Fidler et al.
CANCER AND METASTASIS REVIEWS (2015)
Abscopal effects of radiation therapy: A clinical review for the radiobiologist
Shankar Siva et al.
CANCER LETTERS (2015)
Rho Kinase Inhibitors Block Melanoma Cell Migration and Inhibit Metastasis
Amine Sadok et al.
CANCER RESEARCH (2015)
Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer
Lewis Quayle et al.
CURRENT CANCER DRUG TARGETS (2015)
GEMMs as preclinical models for testing pancreatic cancer therapies
Aarthi Gopinathan et al.
DISEASE MODELS & MECHANISMS (2015)
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
Eleonor Olsson et al.
EMBO MOLECULAR MEDICINE (2015)
Potentiated DNA Damage Response in Circulating Breast Tumor Cells Confers Resistance to Chemotherapy
Chang Gong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle
Mark J. Ernsting et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Do Circulating Tumor Cells, Exosomes, and Circulating Tumor Nucleic Acids Have Clinical Utility? A Report of the Association for Molecular Pathology
Bert Gold et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2015)
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
R. Coleman et al.
LANCET (2015)
MEK Inhibitor Selumetinib (AZD6244; ARRY-142886) Prevents Lung Metastasis in a Triple-Negative Breast Cancer Xenograft Model
Chandra Bartholomeusz et al.
MOLECULAR CANCER THERAPEUTICS (2015)
The IGF-Trap: Novel Inhibitor of Carcinoma Growth and Metastasis
Ni Wang et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Tumour exosome integrins determine organotropic metastasis
Ayuko Hoshino et al.
NATURE (2015)
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
Xiaofeng Zheng et al.
NATURE (2015)
Neutrophils support lung colonization of metastasis-initiating breast cancer cells
Stefanie K. Wculek et al.
NATURE (2015)
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
Kari R. Fischer et al.
NATURE (2015)
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
Sonia A. Melo et al.
NATURE (2015)
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Bruno Costa-Silva et al.
NATURE CELL BIOLOGY (2015)
A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis
Branden S. Moriarity et al.
NATURE GENETICS (2015)
Suppression of cancer relapse and metastasis by inhibiting cancer stemness
Youzhi Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Isaac Garcia-Murillas et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
CXCR-4 Targeted, Short Wave Infrared (SWIR) Emitting Nanoprobes for Enhanced Deep Tissue Imaging and Micrometastatic Cancer Lesion Detection
Margot Zevon et al.
SMALL (2015)
Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage-Derived VEGFA
Allison S. Harney et al.
CANCER DISCOVERY (2015)
Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis
Sebastien Tabaries et al.
ONCOTARGET (2015)
Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer
Renata D'Alpino Peixoto et al.
CANCER MEDICINE (2015)
Cancer metastases: challenges and opportunities
Xiangming Guan
ACTA PHARMACEUTICA SINICA B (2015)
The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer
W. Xu et al.
GENE THERAPY (2015)
Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up
J. Bellmunt et al.
ANNALS OF ONCOLOGY (2014)
Immunoglobulin and T Cell Receptor Gene High-Throughput Sequencing Quantifies Minimal Residual Disease in Acute Lymphoblastic Leukemia and Predicts Post-Transplantation Relapse and Survival
Aaron C. Logan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
BMP4 Inhibits Breast Cancer Metastasis by Blocking Myeloid-Derived Suppressor Cell Activity
Yuan Cao et al.
CANCER RESEARCH (2014)
Metastases in Immune-Mediated Dormancy: A New Opportunity for Targeting Cancer
Irene Romero et al.
CANCER RESEARCH (2014)
Broad-Spectrum Therapeutic Suppression of Metastatic Melanoma through Nuclear Hormone Receptor Activation
Nora Pencheva et al.
CELL (2014)
Zoledronic Acid Has Differential Antitumor Activity in the Pre- and Postmenopausal Bone Microenvironment In Vivo
Penelope D. Ottewell et al.
CLINICAL CANCER RESEARCH (2014)
Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
Julia A. Beaver et al.
CLINICAL CANCER RESEARCH (2014)
Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone
Penelope D. Ottewell et al.
ENDOCRINE-RELATED CANCER (2014)
Parathyroid Hormone-Related Protein: Potential Therapeutic Target for Melanoma Invasion and Metastasis
Dao Chao Huang et al.
ENDOCRINOLOGY (2014)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer
Irene Zinonos et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Platelets guide the formation of early metastatic niches
Myriam Labelle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Investigation of the essential role of platelet-tumor cell interactions in metastasis progression using an agent-based model
Abhineet Uppal et al.
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2014)
Mechanisms of disseminated cancer cell dormancy: an awakening field
Maria Soledad Sosa et al.
NATURE REVIEWS CANCER (2014)
The Emerging Role of Immunosurveillance in Dictating Metastatic Spread in Breast Cancer
Clare Y. Slaney et al.
CANCER RESEARCH (2013)
Myeloproliferative Neoplasia Remodels the Endosteal Bone Marrow Niche into a Self-Reinforcing Leukemic Niche
Koen Schepers et al.
CELL STEM CELL (2013)
Attenuation of reactive oxygen species by antioxidants suppresses hypoxia-induced epithelial-mesenchymal transition and metastasis of pancreatic cancer cells
Yoshihide Shimojo et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Inhibition of Established Micrometastases by Targeted Drug Delivery via Cell Surface-Associated GRP78
Yu Rebecca Miao et al.
CLINICAL CANCER RESEARCH (2013)
Metastasis Dormancy in Estrogen Receptor-Positive Breast Cancer
Xiang H. -F. Zhang et al.
CLINICAL CANCER RESEARCH (2013)
Recruitment of a Myeloid Cell Subset (CD11b/Gr1mid) via CCL2/CCR2 Promotes the Development of Colorectal Cancer Liver Metastasis
Lei Zhao et al.
HEPATOLOGY (2013)
TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling
Paloma Bragado et al.
NATURE CELL BIOLOGY (2013)
The perivascular niche regulates breast tumour dormancy
Cyrus M. Ghajar et al.
NATURE CELL BIOLOGY (2013)
Spatiotemporal Regulation of Epithelial-Mesenchymal Transition Is Essential for Squamous Cell Carcinoma Metastasis
Jeff H. Tsai et al.
CANCER CELL (2012)
Cathepsin B Inhibition Limits Bone Metastasis in Breast Cancer
Nimali P. Withana et al.
CANCER RESEARCH (2012)
Genomic analysis of circulating cell-free DNA infers breast cancer dormancy
Jacqueline A. Shaw et al.
GENOME RESEARCH (2012)
Effect of Inhibition of the Lysophosphatidic Acid Receptor 1 on Metastasis and Metastatic Dormancy in Breast Cancer
Jean-Claude A. Marshall et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
Matthew R. Smith et al.
LANCET (2012)
PERSPECTIVE The right trials
Patricia S. Steeg
NATURE (2012)
Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
Bradley N. Bidwell et al.
NATURE MEDICINE (2012)
Patient-derived tumour xenografts as models for oncology drug development
John J. Tentler et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Strategies for the discovery and development of therapies for metastatic breast cancer
Bedrich L. Eckhardt et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells
B. Casar et al.
ONCOGENE (2012)
Molecular networks that regulate cancer metastasis
Daniela Spano et al.
SEMINARS IN CANCER BIOLOGY (2012)
Hereditary breast cancer: clinical features and risk reduction strategies
A. Paradiso et al.
ANNALS OF ONCOLOGY (2011)
Bisphosphonates in preclinical bone oncology
Philippe Clezardin et al.
BONE (2011)
MTDH/AEG-1-based DNA vaccine suppresses lung metastasis and enhances chemosensitivity to doxorubicin in breast cancer
Ben-Jiang Qian et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
TGF-beta-RI Kinase Inhibitor SD-208 Reduces the Development and Progression of Melanoma Bone Metastases
Khalid S. Mohammad et al.
CANCER RESEARCH (2011)
CD24 Offers a Therapeutic Target for Control of Bladder Cancer Metastasis Based on a Requirement for Lung Colonization
Jonathan B. Overdevest et al.
CANCER RESEARCH (2011)
Tumor Engraftment in Nude Mice and Enrichment in Stroma-Related Gene Pathways Predict Poor Survival and Resistance to Gemcitabine in Patients with Pancreatic Cancer
Ignacio Garrido-Laguna et al.
CLINICAL CANCER RESEARCH (2011)
Framework models of tumor dormancy from patient-derived observations
Christoph A. Klein
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
Retinoic Acid-Induced Pancreatic Stellate Cell Quiescence Reduces Paracrine Wnt-β-Catenin Signaling to Slow Tumor Progression
Fieke E. M. Froeling et al.
GASTROENTEROLOGY (2011)
Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer
Neveen Said et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow
Yusuke Shiozawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
F. Michael Yakes et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
Karim Fizazi et al.
LANCET (2011)
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
Yoko S. DeRose et al.
NATURE MEDICINE (2011)
Breast-Cancer Adjuvant Therapy with Zoledronic Acid
Robert E. Coleman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Brain metastases as preventive and therapeutic targets
Patricia S. Steeg et al.
NATURE REVIEWS CANCER (2011)
Heterogeneous Blood-Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer
Paul R. Lockman et al.
CLINICAL CANCER RESEARCH (2010)
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
Alison T. Stopeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study
Mitch Dowsett et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance
Hiroshi Tanaka et al.
NATURE MEDICINE (2010)
Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model
Takanori Kitamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Anti-tumour activity of bisphosphonates in preclinical models of breast cancer
Ingunn Holen et al.
BREAST CANCER RESEARCH (2010)
MTDH Activation by 8q22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast Cancer
Guohong Hu et al.
CANCER CELL (2009)
Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche
Janine T. Erler et al.
CANCER CELL (2009)
Differential Enhancement of Breast Cancer Cell Motility and Metastasis by Helical and Kinase Domain Mutations of Class IA Phosphoinositide 3-Kinase
Huan Pang et al.
CANCER RESEARCH (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock-In Mice That Express Chimeric (Murine/Human) RANKL
Paul J. Kostenuik et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
Richard M. Simon et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
The Lysyl Oxidase Inhibitor, β-Aminopropionitrile, Diminishes the Metastatic Colonization Potential of Circulating Breast Cancer Cells
Alla Bondareva et al.
PLOS ONE (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Microenvironmental regulation of metastasis
Johanna A. Joyce et al.
NATURE REVIEWS CANCER (2009)
Systemic spread is an early step in breast cancer
Yves Huesemann et al.
CANCER CELL (2008)
A genome-wide shRNA screen identifies GAS1 as a novel melanoma metastasis suppressor gene
Stephane Gobeil et al.
GENES & DEVELOPMENT (2008)
Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells
Cedric Gaggioli et al.
NATURE CELL BIOLOGY (2007)
Models, mechanisms and clinical evidence for cancer dormancy
Julio A. Aguirre-Ghiso
NATURE REVIEWS CANCER (2007)
Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone Metastases
Allan Lipton et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
In vivo selection for metastasis promoting genes in the mouse
Kiranmai Gumireddy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
Alan Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases
Chih-hung Lee et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Towards third generation matrix metalloproteinase inhibitors for cancer therapy
CM Overall et al.
BRITISH JOURNAL OF CANCER (2006)
Inhibition of Src expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model
JG Trevino et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
A study of the biological receptor activator of nuclear factor-κB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer
JJ Body et al.
CLINICAL CANCER RESEARCH (2006)
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
RN Kaplan et al.
NATURE (2005)
Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism
JL Dai et al.
CANCER RESEARCH (2005)
Retinoids as chemoprevention for head and neck cancer: where do we go from here?
W Smith et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer
MR Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer
HB Grossman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A multigenic program mediating breast cancer metastasis to bone
YB Kang et al.
CANCER CELL (2003)
Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma - A stratification tool for prospective clinical trials
BC Leibovich et al.
CANCER (2003)
Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases
GN Naumov et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: A meta-analysis of the published results of randomized clinical trials
RJ Sylvester et al.
JOURNAL OF UROLOGY (2002)
β4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium
VM Weaver et al.
CANCER CELL (2002)
Metastasis to bone: Causes, consequences and therapeutic opportunities
GR Mundy
NATURE REVIEWS CANCER (2002)
Issues and barriers to development of clinically useful tumor markers: A development pathway proposal
MEH Hammond et al.
SEMINARS IN ONCOLOGY (2002)
Inhibition of cervical lymph node metastasis by marimastat (BB-2516) in an orthotopic oral squamous cell carcinoma implantation model
K Maekawa et al.
CLINICAL & EXPERIMENTAL METASTASIS (2002)
Occult micrometastasis: enrichment, identification and characterization of single disseminated tumour cells
K Pantel et al.
SEMINARS IN CANCER BIOLOGY (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
G Steinbach et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
